Analysis of dendritic cell populations using a revised histological staging of morphoea

British Journal of Dermatology

Volumn 143, Issue 6, 2000, Pages 1183-1192

  Gilmour, T K ^a   Wilkinson, B ^a   Breit, S N ^a   Kossard, Steven ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dermal dendritic cell; Dermal sclerosis; Morphoea; Tenascin; Transforming growth factor 1

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; MONOCLONAL ANTIBODY; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE CLASSIFICATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BIOPSY; CHILD; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0034523563     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03886.x     Document Type: Article

References (33)

1. Evaluation of transforming growth factor β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization
2. Generalised morphoea. Histology of the dermis and tissue
3. Cellular infiltrates in scleroderma skin
4. Endothelial cell apoptosis is a primary pathogenic event underlying skin lesions in avian and human scleroderma
5. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in-situ hybridization
6. In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients
7. CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma
8. Decreased expression of the human progenitor cell antigen (CD34) in morphea
9. Immunocytochemical localization and serologic detection of transforming growth factor β1. Association with type 1 procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphoea, and Raynaud's phenomenon
10. The dermal dendrocyte
11. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin
12. A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin
13. Oral submucosal dendrocytes: Factor XIIIa and CD34 dendritic cell population in normal tissue and fibrovascular lesions
14. Ontogeny and characterisation of factor XIIIa cells in developing human skin
15. Immunohistochemistry study of CD34 positive cells of human dermis
16. Macrophage and dendritic cells in the skin
17. The human progenitor cell antigen (CD34) is localised on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal-shaped cells in Kaposi's sarcoma
18. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumours
19. Novel interactions between dermal dendrocytes and mast cells in human skin
20. Expression of the CD34 gene in vascular endothelial cells
21. Loss of epidermal Langerhans cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis
22. Cellular immune dysfunction and the pathogenesis of scleroderma
23. The spindle-shaped cells in cutaneous Kaposi's sarcoma
24. Expression of HLA class II antigens on skin fibroblasts in scleroderma
25. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-γ and tumour necrosis factor α in the early disease stage
26. Dermoepidermal separation is associated with induced tenascin expression in human skin
27. Increased expression of tenascin in the dermis of scleroderma
28. Nodular scleroderma: Focally increased tenascin expression differing from that in the surrounding scleroderma skin
29. Immunohistological demonstration of transforming growth factor-β isoforms in the skin of patients with systemic sclerosis
30. Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis
31. Some recent advances in the chemistry and biology of transforming growth factor-β
32. Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo
33. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis